The progress of cerebrospinal fluid biomarkers in patients with neurodegenerative diseases
Neurodegenerative diseases include a heterogeneous group of diseases with complicated and overlapped clinical phenotypes. It is difficult to diagnose or identify this kind of disease due to insidious onset and chronic and progressive development. Since processes in the brain can be monitored by anal...
Main Authors: | Li-li YANG, Wei-zhi WANG |
---|---|
Format: | Article |
Language: | English |
Published: |
Tianjin Huanhu Hospital
2013-02-01
|
Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
Subjects: | |
Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/658 |
Similar Items
-
Cerebrospinal fluid biomarkers in early diagnosis of Alzheimer's disease
by: Jun WANG, et al.
Published: (2014-04-01) -
Fluid biomarkers for the diagnosis of neurodegenerative diseases
by: Matthew Luebke, et al.
Published: (2023-06-01) -
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
by: Ahmed Noor Eddin, et al.
Published: (2023-07-01) -
CEREBROSPINAL FLUID BIOCHEMICAL STUDIES IN PATIENTS WITH PARKINSON’S DISEASE: TOWARDS A POTENTIAL SEARCH FOR BIOMARKERS FOR THIS DISEASE
by: Félix Javier eJiménez-Jiménez, et al.
Published: (2014-11-01) -
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
by: Sonia M. Vallabh, et al.
Published: (2020-06-01)